- Xcessbio|产品目录|蚂蚁淘试剂代理
- 专利英语1_wang_limei的专栏
- Maradin Ltd. | 进口采购网代理采购欧美工业品
- Xcess公司,Xcess代理商,Xcess经销商,Xcess厂家直采,Xcess官网...
- 日本哥伦布斯columbus日本哥伦布斯columbus批发、促销价格、产地货源...
- 科普中国人民网kpzg.people.com.cn202124 · 2019全国科普日 “礼赞共和国、智慧新生活”,2019年全国科普日活动现已在全国各地同步启动。人民网科普中国特别打造“科普流言止于我”专题,揭露身边伪科学,让谣言止于你我。典赞·2019科普
- 中性笔
- goldbio上海代理goldbio上海代理|产品详情
- 【佛山汽车网_佛山车市|佛山汽车报价】太平洋汽车网
- AIRGAS
- 05024 SSB琼脂培养基(颗粒)_企业动态
- xcessbio上海代理 xcessbio上海代理|产品详情
| Molecular Weight: | 513.78 |
| Formula: | C16H21ClN3O4S |
| Purity: | ≥98% |
| CAS#: | 1469337-91-4 |
| Solubility: | DMSO up to 100 mM |
| Chemical Name: | N-(1-(2-((4-chloro-5-iodo-2-methoxyphenyl)amino)acetyl)piperidin-4-yl)ethenesulfonamide |
| Storage: | Powder:4oC 1 year. DMSO:4oC3 month;-20oC 1 year. |
Biological Activity:
KRAS-C9 is a potent and selective allosteric inhibitor of oncogenic K-Ras(G12C). It irreversibly binds to a common oncogenic mutant K-Ras(G12C) and blocks K-Ras(G12C) interactions, therefore does not affect the wild-type protein. Binding of KRAS-C9 to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favour GDP over GTP and impairing binding to Raf. It can decrease viability and increase apoptosis of K-Ras(G12C)-containing cancer cell lines. KRAS-C9 provides structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.
How to Use:
- In vitro: KRAS-C9 was used at 10 µM final concentration in various in vitro assays.
- In vivo:n/a
Reference:
- 1. Ostrem JM, et al. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. (2013) Nature. 503(7477):548-51.
KRAS-C9_spec.pdf
KRAS-C9_MSDS.pdf


